HIGHLIGHTS
- who: Lumipulse and collaborators from the Biomedical Research Institute Sant Pau, Universitat Autònoma, Spain have published the article: Molecular Sciences Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center, in the Journal: (JOURNAL) of 11/05/2022
- what: The authors propose automated CLEIA as a good alternative to standard ELISA together with the use of Aβ1-42/Aβ1-40, which contributes to increasing the accuracy of amyloid determination.
- how: The authors showed that although the immunoassays used similar antibody combinations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.